Antenatal Down syndrome screening in the United States in 2001: A survey of maternal-fetal medicine specialists

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 5, 2002, Pages 1230-1234

  Egan, James F X ^a   Kaminsky, Lillian M ^b   DeRoche, Michael E ^b   Barsoom, Michael J ^b   Borgida, Adam F ^b   Benn, Peter A ^b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Down syndrome; Risk adjustment

Indexed keywords

AMNIOCENTESIS; CONFERENCE PAPER; DOWN SYNDROME; FETUS ECHOGRAPHY; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; MEDICAL PRACTICE; MOTHER FETUS RELATIONSHIP; NEWBORN SCREENING; PATIENT COUNSELING; PRENATAL PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; UNITED STATES;

EID: 0036854161     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.126980     Document Type: Conference Paper

References (17)

1. Coustan DR, Schwartz RM, Gagnon DE, VanDorsten JP. The distribution, practice, and attitudes of maternal-fetal medicine specialists. Am J Obstet Gynecol 2001;185:1218-25.
2. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation: Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352:343-6.
3. Vintzileos AM, Egan JF. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 1995;172:837-44.
4. Haddow JE, Palomaki GE, Knight GJ, Foster DL, Neveux LM. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. J Med Screen 1998;5:115-9.
5. Smith-Bindman R, Hosmer W, Feldstein VA, Deeks JJ, Goldberg JD. Second-trimester ultrasound to detect fetuses with Down syndrome: A meta-analysis. JAMA 2001;285:1044-55.
6. Tabor APJ, Madsen M, Bang J, Obel EB, Norgaard-Pederson B. Randomised controlled trial of genetic amniocentesis in 4606 low risk women. Lancet 1986;1:1287-93.
7. American College of Obstetricians and Gynecologists. Compendium of selected publications. Washington (DC): The College; 2002. Practice bulletin No.: 27:457-67.
8. NIH consensus development conferences. Antenatal diagnosis: Amniocentesis. Clin Pediatr 1979;18:454-62.
9. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-94.
10. Wald NJ, Cuckle HS, Demsem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down syndrome in early pregnancy. BMJ 1988;297:883-7.
11. Wald NJ, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down's syndrome. J Med Screen 1997;4:181-246.
12. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999;341:461-7.
13. Nyberg DA, Souter VL. Sonographic markers of fetal trisomies: Second trimester. J Ultrasound Med 2001;20:655-74.
14. Egan JF, Malakh L, Turner GW, Markenson G, Wax JR, Benn PA. Role of ultrasound for Down syndrome screening in advanced maternal age. Am J Obstet Gynecol 2001;185:1028-31.
15. Egan JF, Benn P, Borgida AF, Rodis JF, Campbell WA, Vintzileos AM. Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997. Obstet Gynecol 2000;96:979-85.
16. Benn PA, Ying J, Beazoglou T, Egan JF. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Prenat Diagn 2001;21:46-51.
17. Blessed WH, Lacoste H, Welch RA. Obstetrician-gynecologists performing genetic amniocentesis may be misleading themselves and their patients. Am J Obstet Gynecol 2001;184:1340-4.